Organ support & nutrition

Prevalence and prognostic relevance of invasive fungal disease during veno-arterial extracorporeal membrane oxygenation (ECMO): A retrospective single-center study

J Crit CarePublished Retrospective cohort study

Authors' conclusion

IFD are detected in about one in 20 patients on V-A ECMO, indicating mortality >90%. However, IFD do not contribute to prognosis in this population.

Study context

Population
Adults on veno-arterial ECMO at a German University Hospital, January 2013 to November 2023421 received veno-arterial (V-A) ECMO
Participants
392 adults
Exposure
Invasive fungal disease (IFD) vs non-IFD
  • IFDn = 18
  • non-IFDn = 374reference
Outcome
Prevalence of invasive fungal disease
Methodological detailssingle-centre, multivariable logistic regression, propensity-score matched
  • Single-centre
  • Multivariable logistic regression
  • Propensity-score matched

Main finding

As reported in the abstract

Prevalence of IFD, invasive candidiasis and probable invasive pulmonary aspergillosis

Prevalence of IFD

4.6%

Prevalence of invasive candidiasis

3.8%

Prevalence of probable invasive pulmonary aspergillosis

1.0%

Observational data: associations, not effects.

Further findings

In-hospital mortality

P = 0.0156

OutcomeOR (CI)P value
In-hospital mortality8.31 (1.60–153.18)p: 0.044
  • In-hospital mortality: multivariable; other predictors female sex, SOFA score at admission, SAVE score

Predictors of IFD

Severity of acute disease, pre-existing moderate-to-severe renal disease and continuous kidney replacement therapy predictive of IFD

Outcome after propensity-score matching

No difference in outcome after matching IFD-cases to non-IFD-controls
  • Matched cohort

Original publication

Prevalence and prognostic relevance of invasive fungal disease during veno-arterial ECMO: A retrospective single-center study. J Crit Care. Published 25 May 2024. doi:10.1016/j.jcrc.2024.154831

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.